An Expanded Oct4 Interaction Network: Implications for Stem Cell Biology, Development, and Disease  by Pardo, Mercedes et al.
Cell Stem Cell
ResourceAn Expanded Oct4 Interaction Network: Implications
for Stem Cell Biology, Development, and Disease
Mercedes Pardo,1,4,* Benjamin Lang,3,4 Lu Yu,1 Haydn Prosser,2 Allan Bradley,2 M. Madan Babu,3,5
and Jyoti Choudhary1,5,*
1Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
2Mouse Genomics, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK
3MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK
4These authors contributed equally to this work
5These authors contributed equally to this work
*Correspondence: mp3@sanger.ac.uk (M.P.), jc4@sanger.ac.uk (J.C.)
DOI 10.1016/j.stem.2010.03.004
Open access under CC BY license.SUMMARY
The transcription factorOct4 is key inembryonic stem
cell identity and reprogramming. Insight into its part-
ners should illuminate how the pluripotent state is
established and regulated. Here, we identify a con-
siderably expanded set of Oct4-binding proteins in
mouse embryonic stem cells. We find that Oct4 asso-
ciates with a varied set of proteins including regula-
tors of gene expression andmodulators of Oct4 func-
tion.Half of itspartners are transcriptionally regulated
by Oct4 itself or other stem cell transcription factors,
whereas one-third display a significant change in
expression upon cell differentiation. The majority of
Oct4-associated proteins studied to date show an
early lethal phenotype when mutated. A fraction of
the human orthologs is associated with inherited
developmental disorders or causative of cancer.
The Oct4 interactome provides a resource for dis-
secting mechanisms of Oct4 function, enlightening
the basis of pluripotency and development, and iden-
tifying potential additional reprogramming factors.
INTRODUCTION
Two characteristics define embryonic stem cells (ESCs), self-
renewal ability and pluripotency. Recently, ectopic expression
of combinations of transcription factors (Oct4, Nanog, Sox2,
c-Myc, Esrrb, and Klf4) has been shown to reprogram mouse
and human fibroblasts into a pluripotent state (Kaji et al., 2009;
Okita et al., 2007; Takahashi et al., 2007; Takahashi and Yama-
naka, 2006; Woltjen et al., 2009; Yu et al., 2007). The induced
pluripotent stem cells (iPSCs) are very similar to ESCs and retain
the ability to self-renew and differentiate into the three germ
layers and thus promise great therapeutic potential in regenera-
tivemedicine (Amabile andMeissner, 2009;Maherali et al., 2007;
Wernig et al., 2007). Despite the recent flurry of studies, our
understanding of the molecular mechanisms and players that
drive ESC self-renewal and differentiation is still limited.
The POU transcription factor Oct4, also termed Pou5f1, is a
central player in ESC self-renewal and differentiation into
specific lineages. Levels of Oct4 must be tightly regulated to382 Cell Stem Cell 6, 382–395, April 2, 2010 ª2010 Elsevier Inc.maintain the ESC status. A decrease in Oct4 levels by 50%
induces differentiation toward the trophectoderm lineage,
whereas a 50% increase causes differentiation into mesoderm
and endoderm (Niwa et al., 2000; Shimozaki et al., 2003). Oct4
plays an essential role in early development given that loss of
Oct4 in the mouse embryo causes the failure of the inner cell
mass to develop (Nichols et al., 1998).
Oct4 regulates transcriptional programs to maintain ESC plu-
ripotency primarily in collaboration with transcription factors
Sox2 and Nanog (Boyer et al., 2005; Chew et al., 2005; Pan
et al., 2006). Several genome-wide analyses of regulatory targets
of key pluripotency factors has led to the identification of sets of
jointly regulated or bound targets, highlighting a complex tran-
scriptional circuitry responsible for ESC maintenance (Babaie
et al., 2007; Boyer et al., 2005; Ivanova et al., 2006; Kim et al.,
2008; Loh et al., 2006;Matoba et al., 2006). Also recently, various
other factors have been functionally linked to Oct4 and Nanog,
after identification of their binding partners by affinity purification
and mass spectrometry (Wang et al., 2006, Liang et al., 2008).
These studies have revealed a compact regulatory module
responsible for ESC pluripotency (Orkin et al., 2008).
To further elucidate the ESC transcriptional network, we have
carried out an unbiased and extensive study of Oct4-associated
proteins, using an affinity purification and mass spectrometry
approach. In contrast with a previous similar study (Wang et al.,
2006), epitope-tagged Oct4 was expressed under the control of
Oct4’s endogenous promoter to keep the natural transcriptional
regulation. The epitope tagging strategy circumvents the need
for specific antibodies and facilitates a generic purification pro-
cedure that results in cleaner and higher yield samples than
traditional immunoprecipitation experiments. Our data signifi-
cantly expands the current repertoire of Oct4-associated pro-
teins, thereby shedding light on the complex regulatory circuitries
of ESCs. The Oct4 interactome provides a useful resource to
investigate the mechanisms of Oct4 function and regulation
and to explore the basic principles underlying stem cell biology.RESULTS
Efficient FTAP Tagging of Oct4 by Recombineering
and Single-Copy BAC Transgenesis
To investigate the molecular network around Oct4/Pou5f1,
we used an epitope-tagging affinity purification strategy.
Figure 1. Analysis of Oct4-Interacting
Proteins
(A) Typical Oct4-FTAP and control purifications.
Molecular weight markers (kDa) are shown.
(B) Western blots confirming some of the interact-
ing proteins identified by mass spectrometry. C,
Western blot showing co-immunoprecipitation of
endogenous Parp1 with Oct4 in the presence
(B+) or absence (B-) of benzonase. In denotes
whole cell extract. D, Workflow tracing the sys-
tems analyses of the Oct4 interactome. E,
Network of protein-protein interactions within the
Oct4 dataset. Blue circles are proteins downregu-
lated upon ES cell differentiation. Red fill indicates
proteins whose absence results in embryonic
lethality in the mouse. See also Figure S1.
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the 33 FLAG epitope and a calmodulin binding peptide (CBP)
separated by a TEV cleavage site, by adding an extra TEV site
to improve cleavage efficiency (Figure S1A available online).
The FTAP was fused at the C terminus of the Oct4 coding region
by recombineering into a BAC clone containing full-length Oct4.
This was then integrated into the Hprt locus of ESCs by recom-
binase-mediated cassette exchange (RMCE) (Prosser et al.,
2008). The whole procedure is depicted in Figure S1B. Expres-
sion levels of the Oct4-FTAP fusion protein were 30% that of
endogenousOct4 expressed from two alleles (Figure S1C), close
to what should be expected given that it is expressed from an
extra copy of the gene and avoiding interference with the ESC
phenotype, as shown by the expression of ESC markers by the
transgenic clone (Figure S1C).
Identification of Oct4-Associated Proteins
The tandem affinity tag allows single- and double-affinity purifi-
cations. We first performed three independent one-step purifi-Cell Stem Cell 6, 382–cations on whole-cell extracts from
both Oct4-FTAP-expressing and control
unmodified cells (Figure 1A). Eluates
were separated by gel electrophoresis,
and whole lanes were excised into
several regions, digested, and analyzed
by nano-liquid chromatrography/tandem
mass spectrometry (LC-MS/MS). MS
results files from each lane were merged
and searched against IPI with Mascot.
The data is available in the PRIDE data-
base (Martens et al., 2005) (www.ebi.ac.
uk/pride). The data was converted with
the PRIDE Converter (Barsnes et al.,
2009) (http://code.google.com/p/pride-
converter). The criteria for peptide and
protein identification are detailed in
Experimental Procedures. Mass spec-
trometry analysis resulted in the identifi-
cation of 92 proteins (excluding Oct4
itself) that were present in all Oct4-FTAP
purifications, but not in controls (Table 1).
The identification of some of the interact-ing proteins was confirmed by Western blotting (Figure 1B).
These data considerably expand the list of published Oct4
binding partners and represent a major extension of the sets
reported in two similar studies (Liang et al., 2008; Wang et al.,
2006). We detected 13 previously identified Oct4 interacting
proteins in our study (Table S6). These included Sall4, Arid3b,
Zfp219, and Sp1 (Wang et al., 2006), Kpna2 (Li et al., 2008),
Parp1 (Gao et al., 2009), and NuRD complex members Hdac1,
Mta1/2, and Gatad2a/b (Liang et al., 2008; Wang et al., 2006).
Furthermore, we also identified Sox2 and Nanog, two of the
best characterized Oct4 binding partners (Ambrosetti et al.,
1997; Chew et al., 2005; Liang et al., 2008; Wang et al., 2006),
and Zfp281, Requiem/Dpf2, Yy1, RYBP, Dax1, Esrrb, and
Arid3a, recently shown to physically interact with Oct4 (Donohoe
et al., 2009; Sun et al., 2009; van den Berg et al., 2008; Wang
et al., 2006; Wang et al., 2008) in one or two (Arid3a and Esrrb)
purifications, but because of our strict criteria of result reproduc-
ibility, we did not include them in the final data set. We also iden-
tified proteins reported to be linked to Oct4 through association395, April 2, 2010 ª2010 Elsevier Inc. 383
Table 1. Oct4-Associated Proteins Classified into Protein Complexes and/or Functional Categories
Complex/
Protein Class
Gene
Name Accession Description MW Exp I Exp II Exp III
Bait Pou5f1 IPI00117218 POU domain, class 5, transcription factor 1 38705.35 20 19 21
NuRD Complex
Chd4 IPI00396802 chromodomain-helicase-DNA-binding protein 4 219096.34 21 40 33
Gatad2a IPI00625995 p66 alpha isoform a 67762.39 13 11 16
Gatad2b IPI00128615 isoform 1 of transcriptional repressor p66-beta 65712.08 13 7 16
Mbd3 IPI00131067 isoform 1 of methyl-CpG-binding domain protein 3 32168 4 6 4
Mta1 IPI00624969 Mta1 protein 80019.75 13 14 16
Mta2 IPI00128230 metastasis-associated protein MTA2 75723.93 25 17 21
Mta3 IPI00125745 isoform 1 of metastasis-associated protein MTA3 67719.08 10 9 7
Hdac1 IPI00114232 histone deacetylase 1 55609.93 11 12 11
Spalt-like Transcriptional Repressors
Sall1 IPI00342267 Sal-like 1 141745.1 11 17 18
Sall3 IPI00123404 isoform 1 of Sal-like protein 3 140610.62 5 5 6
Sall4 IPI00475164 isoform 1 of Sal-like protein 4 114711.29 35 29 28
BAF Complex
Smarca4 IPI00875789 SWI/SNF related, matrix associated, actin
dependent regulator of chromatin, subfamily a,
member 4, isoform CRA_b
181913.68 3 5 1
Smarcc1 IPI00125662 isoform 1 of SWI/SNF complex subunit SMARCC1 123326.28 7 3 4
Actl6a IPI00323660 actin-like protein 6A 47930.54 4 1 1
FACT Complex
Ssrp1 IPI00407571 isoform 2 of FACT complex subunit SSRP1 81766.73 36 12 32
Supt16h IPI00120344 FACT complex subunit SPT16 120319.5 64 34 56
LSD1 Complex
Aof2 IPI00648295 amine oxidase (Flavin containing) domain 2 95113.5 9 6 7
Rcor2 IPI00226581 REST corepressor 2 58042.89 5 6 2
ISWI
Chromatin
Remodeling
Complex
Smarca5 IPI00396739 SWI/SNF-related matrix-associated
actin-dependent regulator of chromatin
subfamily A member 5
122291.43 5 7 2
INO80 Chromatin-Remodeling Complex
Ino80 IPI00378561 isoform 1 of putative DNA helicase
INO80 complex homolog 1
177265.25 5 6 1
Nfrkb IPI00274469 nuclear factor related to kappa-B-binding protein 139134.5 22 11 4
Actl6a IPI00323660 actin-like protein 6A 47930.54 4 1 1
Histone Chaperone Complex
Asf1a IPI00132452 histone chaperone ASF1A 23099.19 3 1 3
Cabin1 IPI00380107 calcineurin binding protein 1 245584.2 8 18 7
Hira IPI00123694 isoform long of protein HIRA 113235.4 10 7 10
Ubn2 IPI00854896 isoform 4 of uncharacterized protein KIAA2030 142523.51 17 19 11
Transcription Factors
Arid3b IPI00277032 isoform 1 of AT-rich interactive
domain-containing protein 3B
61091.99 9 8 3
Atf2 IPI00110172 isoform 1 of cyclic AMP-dependent
transcription factor ATF-2
52550.73 4 5 5
Creb1 IPI00119924 isoform 1 of cAMP response
element-binding protein
36879.65 3 3 3
Ctbp1 IPI00128155 isoform 1 of C-terminal-binding protein 1 48170.7 9 4 3
Ctbp2 IPI00856974 isoform 2 of C-terminal-binding protein 2 107801.19 10 3 4
Klf4 IPI00120384 Kruppel-like factor 4 52531.81 1 1 2
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Table 1. Continued
Complex/
Protein Class
Gene
Name Accession Description MW Exp I Exp II Exp III
Mitf IPI00125758 isoform A of microphthalmia-associated
transcription factor
59160.39 2 3 1
Nfyc IPI00108204 nuclear transcription factor Y subunit gamma 37230.86 7 3 1
Sp1 IPI00323887 isoform 1 of transcription factor Sp1 81309.84 5 4 6
Tcfe3 IPI00380308 isoform 1 of transcription factor E3 61555.7 9 5 7
Tcfeb IPI00314502 transcription factor EB 52638.18 2 3 2
Zbtb10 IPI00223276 zinc finger and BTB domain containing
10 isoform 1
118071.48 9 5 12
Zbtb2 IPI00652356 putative uncharacterized protein 58189.61 1 1 1
Zbtb43 IPI00230530 zinc finger protein 297B isoform a 57551.37 2 1 3
Zfhx3 IPI00475055 AT motif binding factor 1 410697.11 3 36 1
Zfp217 IPI00758403 zinc finger protein 217 115181.65 11 10 4
Zfp219 IPI00469594 zinc finger protein 219, isoform CRA_a 78831.33 4 6 7
Zfp513 IPI00830836 isoform 1 of Zinc finger protein 513 59968.12 1 2 1
Zic2 IPI00127145 zinc finger protein ZIC 2 55546.36 1 1 1
Zscan4b IPI00755380 similar to Gene model 397 58667.99 4 6 7
Regulation of Transcription
Acin1 IPI00121136 isoform 1 of apoptotic chromatin condensation
inducer in the nucleus
151000.03 12 2 13
Brwd1 IPI00121655 isoform A of bromodomain and WD
repeat-containing protein 1
262057.12 1 2 2
Hcfc1 IPI00828490 host cell factor C1 216798.82 19 8 12
Ifi202b IPI00126725 interferon-activable protein 202 50727.44 4 6 3
Phf17 IPI00453799 isoform 1 of Protein Jade-1 95434.25 4 2 4
Rfx2 IPI00406298 DNA-binding protein RFX2 76998.5 8 1 1
General
Transcription
Ttf2 IPI00112371 transcription termination factor 2 126706.43 5 2 2
Recombination/Repair
Lig3 IPI00124272 isoform Alpha of DNA ligase 3 114656.59 5 6 1
Msh6 IPI00310173 MutS homolog 6 152813.37 10 4 5
Parp1 IPI00139168 putative uncharacterized protein 113491.6 24 17 33
Top2a IPI00122223 DNA topoisomerase 2-alpha 173567.4 30 44 12
Xrcc1 IPI00118139 DNA repair protein XRCC1 69270.68 6 3 1
Xrcc5 IPI00321154 ATP-dependent DNA helicase 2 subunit 2 83802.29 6 5 13
Xrcc6 IPI00132424 ATP-dependent DNA helicase 2 subunit 1 69726.04 12 5 12
Replication
Rpa1 IPI00124520 replication protein A 70 kDa DNA-binding subunit 69620.87 2 3 2
Rpa3 IPI00132128 replication protein A 14 kDa subunit 13688.99 1 1 1
Helicases
Chd1 IPI00107999 chromodomain-helicase-DNA-binding protein 1 197601.13 8 9 7
Chd3 IPI00675483 chromodomain helicase DNA binding protein 3 234196.54 5 6 6
Chd5 IPI00875673 chromodomain helicase DNA
binding protein 5 isoform1
224027.21 10 9 11
Dhx9 IPI00339468 isoform 2 of ATP-dependent RNA helicase A 150907.1 15 15 31
Hells IPI00121431 isoform 1 of lymphocyte-specific helicase 95806.47 3 1 1
Histones
Hist1h3e IPI00282848 histone cluster 2, H3c1 isoform 2 20348.12 8 9 4
Hist1h4b IPI00407339 histone H4 11360.38 11 13 6
Hist3h2bb IPI00229539 histone cluster 3, H2bb 17248.15 9 7 4
(Continued on next page)
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Table 1. Continued
Complex/
Protein Class
Gene
Name Accession Description MW Exp I Exp II Exp III
Heterogeneous Nuclear Ribonucleoproteins
Hnrnpab IPI00277066 heterogeneous nuclear ribonucleoprotein
A/B isoform 1
36302.44 3 2 2
Hnrnpl IPI00620362 heterogeneous nuclear ribonucleoprotein L 64550.49 10 4 8
Hnrnpu IPI00458583 putative uncharacterized protein 88661.02 8 2 12
Histone Ubiquitination (E3 Ubiquitin Ligase Complex)
Cul4b IPI00224689 Cullin 4B 111314 7 3 9
Ddb1 IPI00316740 DNA damage-binding protein 1 128026.73 7 5 16
Enzymes
Cad IPI00380280 carbamoyl-phosphate synthetase 2, aspartate
transcarbamylase, and dihydroorotase
245649.59 4 18 11
Dnmt3a IPI00131694 isoform 1 of DNA (cytosine-5)-methyltransferase 3A 103203.53 4 4 7
Dnmt3l IPI00109459 DNA (cytosine-5)-methyltransferase 3-like 49159.08 7 3 7
Myst2 IPI00228457 isoform 2 of histone acetyltransferase MYST2 67588.54 4 2 3
Ogt IPI00420870 isoform 1 of UDP-N-acetylglucosamine–peptide
N-acetylglucosaminyltransferase 110 kDa subunit
118131.41 14 4 10
P4ha1 IPI00399959 isoform 2 of prolyl 4-hydroxylase subunit alpha-1 61132.82 14 5 5
Ppp2r1a IPI00310091 Serine/threonine-protein phosphatase 2A 65 kDa
regulatory subunit A alpha isoform
66079.23 3 4 1
Trim24 IPI00227778 isoform short of transcription
intermediary factor 1-alpha
114824.79 3 4 6
Trim33 IPI00409904 isoform alpha of E3 ubiquitin-protein ligase TRIM33 125931.28 2 2 2
Karyopherins
Kpna2 IPI00124973 Importin subunit alpha-2 58234.28 7 7 2
Kpna3 IPI00230429 Importin subunit alpha-3 58193 2 1 2
Chaperones Dnaja1 IPI00132208 DnaJ homolog subfamily A member 1 45580.73 6 1 5
Proteasome Psmb6 IPI00119239 proteasome subunit beta type-6 25590.57 2 2 1
Nuclear Assembly/Organization
Emd IPI00114401 Emerin 29417.38 2 1 1
Matr3 IPI00453826 Matrin-3 95085.04 14 6 11
Miscellaneous
Amotl2 IPI00263333 isoform 1 of Angiomotin-like protein 2 85454.32 1 4 2
Cubn IPI00889898 Cubilin 407679.63 3 7 2
Nudc IPI00132942 nuclear migration protein nudC 38334.29 2 2 2
The number of unique peptides for three independent experiments is shown. MW, molecular weight. See also Table S6.
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An Expanded Oct4 Interaction Networkwith some of its interactors, namely Sall1 and Smarcc1 (Wang
et al., 2006). Eight previously identified Oct4-interacting proteins
were either not detected, namely EWS, NF45, Cdk1 (Wang et al.,
2006), and Zfp206 (Yu et al., 2009), or found also in controls,
such as beta-catenin (Takao et al., 2007), Hdac2 (Liang et al.,
2008), Ctcf (Donohoe et al., 2009), and Wwp2 (Xu et al., 2009;
Xu et al., 2004).
We next performed tandem affinity purification, although
yields were not high because of the low levels of tagged Oct4
and purification efficiency. We identified seven proteins of the
92, mainly members of NuRD, Sall proteins, and transcription
factors E3 and EB (Table S6). We believe these constitute the
highest-affinity interactors, given that they can endure a more
stringent purification. Although yielding small numbers of inter-
actors, this purification is still at the level of previous similar
studies (Liang et al., 2008; Wang et al., 2006).386 Cell Stem Cell 6, 382–395, April 2, 2010 ª2010 Elsevier Inc.For confirmation, we immunoprecipitated endogenous Oct4
from whole-cell extracts of untagged feeder-free E14 mouse
ESCs in duplicate and analyzed immunoprecipitates by mass
spectrometry. Forty-six proteins reproducibly overlapped with
the FTAP data set (Table S6). We detected all proteins identified
in a similar experiment (Liang et al., 2008). Not surprisingly,
proteins that were reproducibly copurified with endogenous
Oct4 tended to be more abundant in our single-affinity purifica-
tion data set.
To address whether the interactions detected were due to
coassembly of factors on chromatin, we then immunoprecipi-
tated Oct4 in the presence of DNase treatment with benzonase.
Western blotting showed that Parp1, a ubiquitous DNA-binding
protein, coimmunoprecipitates with Oct4 even in the absence
of DNA (Figure 1C). Preliminary purification experiments with
a differently tagged Oct4-FTAP cell line suggested that other
Cell Stem Cell
An Expanded Oct4 Interaction NetworkDNA-binding proteins such as ligase 3 and topoisomerase 2a
also copurify with Oct4 in the absence of DNA (M.P. and S.P.
Shen, data not shown). This suggests that the interactions we
detect are not DNA mediated.
Summing up, over 50% of the Oct4-associated proteins (47
of 92) varying in abundance across our data set have been
confirmed by independent means, suggesting that the data set
we provide here is a bona fide set of Oct4 binding partners.
Functional Annotation Analysis of Oct4-Associated
Proteins
To uncover general trends in the functions of the Oct4-interact-
ing proteins, we carried out computational systems-level anal-
yses in a workflow depicted in Figure 1D. We first performed
a functional annotation analysis using DAVID 2008 (Dennis
et al., 2003) and the PANTHER database (Thomas et al., 2003).
We found an enrichment of GO terms such as nucleus, chromo-
some, and chromatin in the cellular component ontology; nucleic
acid binding, protein binding, transcription factor activity, in the
molecular function ontology; and transcription, regulation of
gene expression, and embryonic development in the biological
process ontology (Figure S2 and Table S2). This indicates that
GO terms associated to Oct4 are highly represented within the
list of Oct4-copurifying proteins, adding consistency to the
data set. Twenty proteins in the data set (21%) are annotated
with the GO term ‘‘transcription factor activity.’’ Oct4 has been
shown to associate with several transcription factors, and our
results agree with the notion that combinatorial binding among
pluripotency factors, which contributes to achieving specificity
in gene regulation, may be a frequent pattern in ESCs (Chambers
and Tomlinson, 2009).
We also analyzed the enrichment of proteins involved in
cellular pathways. DAVID analysis detected an enrichment of
proteins involved in the control of gene expression by vitamin
D nuclear hormone receptor, mainly members of the FACT and
SWI/SNF complexes. The data set also contains several proteins
involved in the nuclear part of the Wnt signaling pathway, as
revealed by PANTHER analysis. The Wnt pathway is involved
in stem cell maintenance (Anton et al., 2007; Sato et al., 2004),
possibly by modulating levels of pluripotency factors Oct4,
Nanog, and Sox2 (Kalmar et al., 2009).
We then analyzed the domain composition of Oct4-interacting
proteins and detected a significant abundance of DNA-binding
and chromatin-related domains (Tables S3 and S4). Highly
represented domains were DEAD/DEAH box helicase, SNF2-
related, PHD and zinc fingers, and chromo, bromo, and homeo-
box domains, all of which are either involved in ATP-dependent
chromatin remodeling or bind DNA and posttranslationally modi-
fied nucleosomes, thereby influencing gene expression.
The data set was manually classified into known protein com-
plexes and functional categories. As shown in Table 1 and sup-
ported by the GO and PANTHER analyses, Oct4 associates
mainly with transcriptional regulators, but also with a variety of
other chromatin binding proteins involved in DNA replication,
recombination, and repair, proteins involved in nuclear assembly
and/or organization, and diverse enzymes, some of which are
responsible for addition of posttranslational modifications.
To gain an overall view of the previously known interactions
among Oct4-associated proteins, we retrieved interaction datafrom INTACT, HRPD, and MINT for the data set and represented
them as a protein interaction network (Figure 1E). The network
comprises 80 known interactions for 57 of the proteins including
Oct4. Repressor complexes NuRD and SWI/SNF and DNA
repair and de novo DNA methylation modules are apparent in
the network.
Transcriptional Regulation of Oct4-Associated Proteins
Many known Oct4 binding proteins are ESC-specific factors
(Wang et al., 2008). However, Oct4 has also been shown to
interact with more general modulators of transcription that
are expressed ubiquitously, such asmembers of the NuRD com-
plex (Liang et al., 2008; Orkin et al., 2008; Wang et al., 2006). We
investigated the patterns of expression of the Oct4-associated
data set in cells at different stages of differentiation, including
embryonic carcinoma, embryonic stem cells, embryoid bodies,
and various differentiated cell types, on the basis of transcrip-
tomics data (Campbell et al., 2007). Protein abundances were
fairly varied and most interactors maintained near constant
expression across the samples analyzed (Figure 2). This sug-
gests that Oct4 interacts mostly with proteins that are ubiqui-
tously expressed in both differentiated and undifferentiated
cells. After statistical analysis, 33 Oct4-interacting proteins were
found to be significantly less expressed in differentiated cells
compared to ESCs, in correlation with Oct4’s expression pattern
(Figure 2 and Table S6). Among these are the DNA methylation
regulatory factor Dnmt3l and the developmentally important
transcription factors Klf4, Sall1, and Sall4. We observed that
many complexes or interacting pairs in the interaction network
contained at least one member significantly downregulated
upon ESC differentiation (Figure 1E), possibly conferring an
ESC-specific role.
Regulation of gene expression involves complex dynamics
employing sequence-specific DNA binding proteins that form
the transcriptional regulatory network (Babu et al., 2004; Jothi
et al., 2009; Luscombe et al., 2004). Transcription factors often
operate in feedback loops, whereby the expression of a tran-
scriptional target modulates the function of the transcription
factor itself (Figure 3A). Pluripotency factors in ESCs are no
exception and show a high degree of transcriptional auto and
interregulation (Orkin et al., 2008). We next investigated whether
the promoters of the Oct4-associated gene set contain binding
sites for transcription factors that are central in the establishment
and maintenance of ESC identity. Promoter binding sites for
nine such transcription factors have previously been identified
by ChIP-on-chip (Kim et al., 2008). These include Oct4, Dax1,
Klf4, c-Myc, Nac1, Nanog, Rex1, Zfp281, and Sox2.
Nine of the 92Oct4-associated proteins were found to be tran-
scriptionally regulated by Oct4 itself in mouse ESCs, and 51% of
genes encoding Oct4 partners are targets of at least one key
ESC transcription factor (Figure S3). This concurs with findings
by others on a much smaller data set (Orkin et al., 2008; Wang
et al., 2006). To assess whether this is statistically significant,
we compared the results to 1000 randomly generated sets of
92 proteins. The expected percentage of promoter binding by
ESC transcription factors was only 28% (Z = 4.45, p < 1015),
indicating that it is a significant trait of the data set. Several genes
in the interaction set are common targets of multiple transcrip-
tion factors (20 of 92 are targets of at least three transcriptionCell Stem Cell 6, 382–395, April 2, 2010 ª2010 Elsevier Inc. 387
-1.5 SD +1.5 SD
EC
 P
19
 E
C 
m
on
o 
1d
EC
 P
19
 E
C 
ag
g 
1d
EC
 P
19
 E
C 
m
on
o 
2d
EC
 P
19
 E
C 
ag
g 
2d
ES
 R
1 
ES
 O
ct
4-
G
FP
 6
47
3
ES
 R
1 
ES
 O
ct
4-
G
FP
 6
99
9
ES
 R
1 
ES
ES
 V
6.
5 
ES
ES
 J
1 
ES
ES
 B
L/
6 
ES
 C
2 
at
t
ES
 B
L/
6 
ES
 C
2 
de
t
ES
 B
L/
6 
ES
 C
2 
ea
rly
ES
 B
L/
6 
ES
 D
4 
at
t
ES
 B
L/
6 
ES
 D
4 
de
t
ES
 B
L/
6 
ES
 D
4 
ea
rly
D
ES
 R
1 
EB
 1
4d
D
ES
 J
1 
EB
 1
4d
 
D
ES
 V
6.
5 
EB
 1
4d
D
ES
 D
3 
os
te
ob
la
st
 d
iff
 3
0d
AS
 N
eu
ro
sp
he
re
s
AS
 N
eu
ro
sp
he
re
s_
wi
ld
 ty
pe
AS
 N
eu
ro
sp
he
re
s_
p1
07
-/-
AS
 B
on
e 
m
ar
ro
w 
CD
45
+S
ca
1+
AS
 B
on
e 
m
ar
ro
w 
CD
45
-S
ca
1-
AS
 B
on
e 
m
ar
ro
w 
CD
45
+S
ca
1+
AS
 B
on
e 
m
ar
ro
w 
CD
45
+S
ca
1-
AS
 B
on
e 
m
ar
ro
w 
Li
n-
Sc
a1
+c
Ki
t-
AS
 B
on
e 
m
ar
ro
w 
Li
n-
AS
 B
on
e 
m
ar
ro
w 
Li
n-
Sc
a1
+c
Ki
t+
AS
 B
on
e 
m
ar
ro
w 
Li
n-
Sc
a1
-c
Ki
t+
AS
 B
on
e 
m
ar
ro
w 
Li
n-
Sc
a1
-c
Ki
t-
AS
 A
di
po
se
 s
ph
er
es
AS
 D
er
m
is 
sp
he
re
s
AS
 M
am
m
os
ph
er
es
AS
 M
yo
sp
he
re
s
AS
 M
yo
sp
he
re
s 
Sc
a1
+
AS
 R
et
in
al
 s
ph
er
es
 fi
rs
t p
as
sa
ge
AS
 R
et
in
al
 s
ph
er
es
 p
rim
ar
y
D
AS
 M
am
m
os
ph
er
es
 d
iff
 6
d
D
AS
 M
yo
sp
he
re
s 
di
ff 
7d
M
 B
on
e 
m
ar
ro
w
 to
ta
l p
op
ul
at
io
n
D
 B
on
e 
m
ar
ro
w
 m
as
t c
el
l p
re
cu
rs
or
s
D
 B
on
e 
m
ar
ro
w
 m
at
ur
e 
m
as
t c
el
ls
2
a
Ppp2r1a
- Ddb1
- Psmb6
Ssrp1
- Hdac1
Hnrnpab
Rpa1
Dnaja1
Matr3
Trim33
- Oct4/Pou5f1
- Dnmt3l
- Sall4
+ P4ha1
- Amotl2
- Ctbp2
- Cad
- Hnrnpl
- Rcor
Mta1
Gatad2a
- Kpna3
- Nudc
- Rpa3
- Mta3
- Trim24
Chd4
Dnmt3a
- Xrcc1
- Hcfc1
- Mbd3
- Phf17
- Xrcc5
- Hells
- Cul4b
- Msh6
- Parp1
- Asf1a
Emd
Nfyc
Hnrnpu
- Smarca5
Smarca4
Supt16h
- Klf4
- Acin1
Mta2
Myst2
- Actl6
Smarcc1
- Xrcc6
Gatad2b
Ogt
Sp1
Zbtb2
Cubn
Rfx2
- Arid3b
- Hira
- Sall1
Sall3
Brwd1
Lig3
Dhx9
Ino80
Chd1
Top2a
Zfhx3
Mitf
Creb1
Zic2
Figure 2. Expression of Oct4-associated proteins in ESCs and Differentiated Cell Types Based on Microarray Data
Columns correspond to experimental samples, arranged as follows: embryonal carcinoma P19 (EC), ES cells (ES), differentiating embryonic stem cells (DES),
adult stem cells (AS), differentiated adult stem cells (DAS), mixed cells (M), and differentiated cells (D). Average-linkage hierarchical clustering was performed
to arrive at the final layout. Genes whose expression is significantly up or downregulated in differentiation are marked.
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An Expanded Oct4 Interaction Networkfactors), making it likely that they have central roles in pluripo-
tency and self-renewal. Ten of these are significantly downregu-
lated in differentiation, and all but two show a downregulation
trend (Table S6), in agreement with the hypothesis that genes
bound by multiple factors are active in ESCs and become
repressed as cells differentiate (Chambers and Tomlinson,
2009; Kim et al., 2008; Orkin et al., 2008). We constructed
a regulatory network by integrating promoter target data for
the nine stem cell transcription factors with the list of Oct4
binding proteins (Figure 3B). Several of the transcription factors
cluster together because of shared targets (e.g., Sox2, Nanog,
Nac1, and Dax1), whereas c-Myc and Klf4 exclusively target
certain groups of Oct4-interacting factors. This agrees with388 Cell Stem Cell 6, 382–395, April 2, 2010 ª2010 Elsevier Inc.the genome-wide trend of the c-Myc target set, which is
largely distinct from the rest of the pluripotency factors (Kim
et al., 2008).
Role of Oct4 Interactome inMouse Embryonic StemCell
Biology and Development
We next explored the consequences of loss of Oct4-interacting
proteins in ESCs or mouse development. Five Oct4-interacting
proteins have been identified as required for stem cell self-
renewal in large scale RNAi screens (Ding et al., 2009;
Hu et al., 2009). Literature searches ascribed a role in ESC
self-renewal or pluripotency to an additional nine Oct4-interact-
ing proteins (Table S6).
AB
Figure 3. Transcriptional Regulation of
Oct4-Associated Proteins
(A) Scheme of transcription factor feedback regula-
tion.
(B) Regulatory network of targets of ESC transcrip-
tion factors among Oct4 partners. Stem cell tran-
scription factors and their target genes among
Oct4-associated proteins are shown in dark and
light gray, respectively. Oct4 and its regulatory
targets are highlighted in blue. See also Figure S3.
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An Expanded Oct4 Interaction NetworkLoss-of-function phenotypes inmice were available in theMGI
database for 49 Oct4-associated proteins. All 49 show diverse
phenotypes when absent or mutated (Figure 4 and Table S5).
Significantly, 83% (41 of 49) of the studied knockout alleles of
the interaction set showed embryonic and/or perinatal lethality,
with over 60% (30 of 49) being embryonic lethal (Figure 1E).
Similar analyses on random control data sets allowed us to
conclude that the result is significant (Z = 7.48, p < 1015).
In addition, 41% (20 of 49) showed an abnormal development0 10 20 30 40 50 60 70
Studied
Not studied
No phenotype observed
Embryonic lethal
Perinatal lethal
Abnormal inner cell mass
Abnormal development
Figure 4. Distribution of Phenotypes Caused by Mutations in the
Genes Encoding Oct4-Associated Proteins
Numbers are percentage of genes studied. Full data are shown in Table S5.
Cell Stem Cell 6, 382phenotype. These results indicate a high
level of requirement for components of
the Oct4 network in early mouse devel-
opment. Although feedback loops are
expected to add to the robustness of
a transcriptional regulatory network,
the high frequency with which mutation
of single Oct4 partners causes severe
early developmental phenotypes sug-
gests they are essential downstream reg-
ulatory hubs.
Involvement of Oct4-Interacting
Proteins in Human Disease
and Cancer
Given the extent of their part in mouse
development and the current excitement
about the cancer stem cell hypothesis,
we next explored a possible role of Oct4-
associated proteins in human disease.
Human orthologs were identified for allOct4-associated proteins and sequence identities determined
between mouse and human (Figure S4). All Oct4-associated
proteins were found to be highly conserved, with a median
sequence identity of 94%, compared to 77% genomic median.
This strong sequence conservation implies that the findings
reported here could be applied to human ESC biology.
We next investigated the involvement of the human orthologs
in human disease and development of cancer interrogating the
OMIM database and the Cancer Gene Census, which records
genes whose mutation has been causally linked to cancer.
Genes encoding 14 of 92 Oct4-associated proteins are impli-
cated in one or more hereditary diseases, mostly of develop-
mental nature, with six of them predisposing to certain types
of cancer (Table 2). Somatic mutations in eight Oct4-associated
proteins and Oct4 itself were found to be responsible for
different types of cancer, often through gene translocations,
presumably affecting their regulation (Table 3). Statistical anal-
ysis on random sets indicated that the observed numbers of
Oct4-interacting proteins linked to human disease (Z = 1.06,
p < 1015) and cancer (Z = 4.43, p < 1015) are significantly
higher than expected.
In light of the central role of Oct4 in pluripotency and the
cancer stem cell hypothesis, we investigated which of Oct4’s
physical interactors are misexpressed in cancer using the
Oncomine human cancer expression database. A large fraction
(60%) of the Oct4 interactors show misexpression in at least–395, April 2, 2010 ª2010 Elsevier Inc. 389
Table 2. Genetic Disease Associations of Oct4-Interacting
Proteins
Gene Disorder Type Disorder
CREB1 cancer histiocytoma, angiomatoid fibrous, somatic
CUBN hematological megaloblastic anemia-1, Finnish type
CUL4B multiple mental retardation syndrome, X-linked,
Cabezas type
mental retardation-hypotonic facies
syndrome, X-linked, 2
EMD muscular Emery-Dreifuss muscular dystrophy
MATR3 muscular myopathy, distal 2
MITF multiple Tietz syndrome
Waardenburg syndrome, type IIA
Waardenburg syndrome/ocular albinism,
digenic
MSH6 cancer colorectal cancer, hereditary
nonpolyposis, type 5
endometrial cancer, familial
mismatch repair cancer syndrome
SALL1 multiple Townes-Brocks branchiootorenal-like
syndrome
Townes-Brocks syndrome
SALL4 multiple Duane-radial ray syndrome
IVIC syndrome
TFE3 cancer renal cell carcinoma, papillary, 1
TRIM24 cancer thyroid carcinoma, papillary
TRIM33 cancer thyroid carcinoma, papillary
ZFHX3 cancer prostate cancer, susceptibility to
ZIC2 developmental holoprosencephaly-5
See also Figure S4.
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connection between stem cell identity and cancer.DISCUSSION
The characterization of protein-protein interactions is a very effi-
cient strategy for understanding protein function and regulation.
The development of high-affinity tags, including the TAP (RigautTable 3. Cancer-Causative Genes among the Oct4-Interacting Prot
Gene Mutation Tiss
CREB1 translocation me
MITF amplification epit
MSH6 Missense, nonsense, frameshift, splice site epit
POU5F1 translocation me
SMARCA4 frameshift, nonsense, missense epit
TFE3 translocation epit
TFEB translocation epit
me
TRIM24 translocation bloo
TRIM33 translocation epit
See also Figure S4.
390 Cell Stem Cell 6, 382–395, April 2, 2010 ª2010 Elsevier Inc.et al., 1999) and in vivo biotinylation tag (de Boer et al., 2003), in
combination with advances inmass spectrometry that now allow
protein identification with high sensitivity and accuracy, has
recently produced several protein interaction network reports.
However, most studies in the literature rely on cDNA overexpres-
sion driven by exogenous promoters or transgenic random
integration approaches.
We report here an epitope-tagging strategy for the purification
of protein complexes in mouse ESCs. We introduced the tag by
recombineering into a full-length Oct4-containing BAC and then
integrated this in a precise location in the mouse genome. This
approach has the advantage of maintaining the endogenous
promoter and therefore natural transcriptional regulation. The
technology is amenable to high-throughput delivery, as recently
demonstrated by random integration of tagged BAC transgenes
(Poser et al., 2008), and should greatly facilitate systematic
tagging of genes and analysis of protein complexes with roles
in development in different contexts, be it in stem cells, differen-
tiated cell types, or even mouse tissue (Ferna´ndez et al., 2009).
The affinity purification method described here is rapid, with
the goal of capturing weak or short-lived interactions. Previous
proteomic studies of Oct4 protein complexes have relied on
lengthy single or tandem purifications from nuclear extracts
with streptavidin capture (Wang et al., 2006) or anti-Oct4 anti-
bodies (Liang et al., 2008) and yielded small data sets, very
similar to our tandem purification data set. We identified all of
the partners reported by the Liang study except Hdac2, and
only five Oct4 partners found in the Wang study were not
detected in our data set, maybe because of our use of whole
extracts. Indeed, our approach has produced by far the most
extensive analysis of Oct4-associated proteins to date.
By using whole extracts, thereby not restricting the analysis
to the nuclear environment, our data set encompasses diverse
aspects of the life of Oct4, both nuclear and nonnuclear.
The broad data set puts Oct4 at the center of diverse cellular
processes that can have an impact on aspects of stem cell
biology (Figure 5), the most interesting of which are discussed
below.
Oct4 can both activate and repress transcriptional targets in
mouse and human ESCs (Babaie et al., 2007; Loh et al., 2006).
To date, Oct4 has been shown to be associated mainly witheins
ue Cancer Type
senchymal clear cell sarcoma, angiomatoid fibrous histiocytoma
helial melanoma
helial colorectal (somatic)
colorectal, endometrial, ovarian (germline)
non-polyposis colorectal cancer (hereditary)
senchymal sarcoma
helial NSCLC (non-small cell lung carcinoma)
helial papillary renal, alveolar soft part sarcoma, renal
helial
senchymal
renal, childhood epithelioid
d APL (acute promyelocytic leukemia)
helial papillary thyroid
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Figure 5. Schematic Model of the Oct4 Interactome
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An Expanded Oct4 Interaction Networkmembers of repressor complexes NuRD and SWI/SNF (Liang
et al., 2008; Wang et al., 2006). We found both among our data
set of Oct4-copurifying proteins. NuRD, a histone deacetylase
complex, was the most prominent, further confirming this link.
Sall4, a well-known Oct4 partner, and other members of the
Spalt-like family of transcriptional cofactors have been shown
to associate to NuRD (Lauberth and Rauchman, 2006), raising
the possibility that they may bridge the interaction between
Oct4 and NuRD. This hypothesis is also supported by the similar
amounts in which they are detected in our experiments. We also
found several subunits of the SWI/SNF nucleosome-remodeler
complex, some of which have previously been linked to Nanog
(Liang et al., 2008), confirming the link to this chromatin remod-
eling complex.
Also amongOct4 binding proteins we found variousmolecules
involved in positive regulation of transcription, including several
activators and coactivators and chromatin-modifying enzymes
such as Myst2, a histone H4 acetyltransferase (Doyon et al.,
2006; Sterner and Berger, 2000). In addition, we detected Ttf2,
a component of the general transcription machinery, providing
evidence of a physical link between pluripotency factors and
basal transcription players. The Oct4 interactome included other
basal DNA-process-related factors such as proteins involved in
DNA replication, recombination, and repair. This could explain
why many of the Oct4-interacting proteins are ubiquitously
expressed in both differentiated and undifferentiated cells.
Our experiments suggest that the interaction is not DNA medi-
ated, given that copurification of DNA-binding proteins still
occurs upon DNA elimination by benzonase.
Importantly, we have uncovered enzymes with a potential
role in Oct4 regulation. Ogt is responsible for posttranslational
addition of O-linked N-acetylglucosamine (O-GlcNAc), a regula-
tory protein modification similar to phosphorylation possibly
working in concert with it (Kamemura and Hart, 2003). Oct4 is
modified by O-GlcNAc in human ESCs (Webster et al., 2009),
and Sp1, one of Oct4 partners, is too (Jackson and Tjian,
1988). A thorough analysis of O-GlcNAc modification in the
Oct4 interactome might yield important insight into dynamic
modulation of stem cell factors. Posttranslational modification
of transcription factors and cofactors is proving to be a criticalcomponent of the regulation of gene transcription in general,
and important specifically in stem cell biology (Brill et al., 2009;
Van Hoof et al., 2009).
Half of Oct4-associated proteins seem to be directly regulated
by transcription factors with key roles in stem cell pluripotency
and/or reprogramming. This is also a characteristic of pluripo-
tency networks derived from smaller data sets from different
entry points (Orkin et al., 2008; Wang et al., 2006). This indicates
that even in the expanded and functionally diverse network,
this attribute still holds true, supporting a previously unsus-
pected role in stem cell biology for some of the proteins we iden-
tify here.
Expression of Oct4 decreases in a switch-like fashion as ESCs
differentiate into lineage-specific cell types, including progenitor
cells. Our analysis has uncovered 33 physical interactors of Oct4
that share this trend. Among these are several transcription
factors, such as the DNA methyltransferase 3-like regulatory
protein Dnmt3l, which stimulates genomic imprinting in germ
cells (Bourc’his et al., 2001; Gowher et al., 2005). This is consis-
tent with a recent report demonstrating that treatment with DNA
methyltransferase inhibitors can improve the efficiency of the
reprogramming process of differentiated cells (Mikkelsen et al.,
2008). Therefore, the 33 interactors upregulated in ESCs and
the transcription factors that regulate them might be interesting
candidates whose expression could be manipulated to facilitate
reprogramming.
We find that loss of function of most Oct4-associated genes
studied to date results in embryonic or perinatal lethality, sug-
gesting that many serve crucial functions in development.
Interestingly, most Oct4-binding proteins linked to a human
hereditary disorder (13 of 14), mostly developmental or cancer
predisposition, give rise to a related phenotype when absent
in the mouse. We find cancer-associated genes, either causal
or predisposing, to be transcriptional regulators involved in pro-
cesses relating to the cell cycle, differentiation, and DNA repair,
acting through chromatin remodeling, signaling, or transcription
factor activity. These results implicate the orthologs of Oct4-
interacting proteins in roles in human development and cancer,
and therefore the data presented here should be useful in eluci-
dating their part in human disease.
In summation, the extensive systems-level analyses
described here compiling data sets of currently available
genome-wide studies provide an integrated vision of the Oct4
interactome. Detailed investigation of this information should
facilitate the choice of candidate factors to test for roles in
ESC maintenance, differentiation, and reprogramming and pro-
vide great insight into the transcriptional regulation of ESC
biology.EXPERIMENTAL PROCEDURES
Generation of FTAP-Tagged Oct4 ESCs
Full details are provided in Supplemental Experimental Procedures. In brief,
the FTAP epitope tag (33FLAG-23TEV-CBP) sequence was synthesized as
two DNA fragments by annealing overlapping complementary oligonucleotide
molecules with PCR. The two fragments were cloned into a modified version
of recombineering vector PL450 (Liu et al., 2003) for pCTR9 creation.
The correctness of the FTAP tag within pCTR9 was confirmed by sequencing.
Homology arms for recombineering were PCR amplified from the Oct4 con-
taining C57Black/6J derived BAC clone (RPCI 23-213M12) and cloned intoCell Stem Cell 6, 382–395, April 2, 2010 ª2010 Elsevier Inc. 391
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An Expanded Oct4 Interaction Networkthe recombineering vector to create pCTS1 (Figure S1). The 50 homology arm
creates an in-frame fusion between the Oct4 C-terminal coding sequence and
the FTAP tag coding sequence, while deleting the stop codon. A fragment for
recombineering the FTAP tag sequence into the Oct4-containing BAC (RPCI
23-213M12) was generated by digesting clone pCTS1. Correct recombination
into E. coli DH10B containing BAC clone RPCI 23-213M12 was confirmed by
Southern analysis of BAC DNA with homology arm-specific DNA probes for all
six tagged BAC clones tested.
ESC cultures, electroporation, and mini-Southern-blot analysis of ESC
clones were as described previously (Ramı´rez-Solis et al., 1993). Integration
of single-copy BAC transgenes at the Hprt locus by recombinase-mediated
cassette exchange (RMCE) has been described previously (Prosser et al.,
2008). For RMCE integration of tagged Oct4 BAC insert into hprttm(rmce1)Brd
allele of CCI18#1.6G, cells were cotransfected with pCAGGS-Cre (Araki
et al., 1997) and the RPCI 23-213M12 BAC clone carrying an integrated
copy of the FTAP tag cassette and neomycin resistance gene. Double-resis-
tant colonies were isolated after successive selection with G418 (200 mg/ml)
and 6-TG (10 mM). Site-specific BAC integration was very efficient, as verified
by Southern analysis with Hprt flanking probes, with 19 of 23 double-resistant
colonies showing correct single-copy integration. For removal of the selection
cassette, the verified ESC clones were transfected with pCAGGS-Flpe (Schaft
et al., 2001) and then selected with FIAU (200 nM). FIAU-resistant subclones
were assessed for selection cassette deletion by Southern blotting. Absence
of a hybridizing 5 kb fragment indicated successful deletion of the selection
cassette. Transgenic clones were analyzed for expression of tagged Pou5f1
by Western blotting, demonstrating that 60% of clones expressed the Oct4-
FTAP fusion protein.
Affinity Purification
Murine ESCs expressing Oct4-FTAP or wild-type control cells (AB2.2) were
separated from feeders by trypsinization and incubation on gelatin-coated
plates for 60min.Whole-cell extracts were incubatedwith anti-FLAGM2Dynal
beads in buffer containing 150 mM NaCl and 0.1% NP-40 for 90 min at 4C.
Anti-FLAG Dynal beads were prepared by crosslinking M2 FLAG antibody
(Sigma) to Protein G-Dynal beads (Invitrogen) in accordance with themanufac-
turer’s instructions. Bound complexes were eluted with AcTEV protease (Invi-
trogen). For tandem affinity purification, the TEV eluate was incubated with
calmodulin resin (Stratagene) for 60 min at 4C. Elution was carried out by
Ca chelation with EGTA. TEV or EGTA eluates were concentrated in Vivaspin
500 PES centrifugal filters (Vivascience), reduced with 1 mM DTT, and alky-
lated with 2 mM iodoacetamide prior to sample fractionation by polyacryl-
amide gel electrophoresis with Novex NuPAGE Bis-Tris 4%–12% gels (Invitro-
gen). Gels were stained with colloidal Coomassie (Sigma) according to Rowley
(Rowley et al., 2000). Whole lanes were cut in 24 slices, destained completely,
and digested with trypsin (sequencing grade, Roche). Peptides were extracted
with 0.5% formic acid 50% acetonitrile and dried in a Speed Vac (Thermo).
Immunoprecipitation and Western Blotting
Oct4 complexes were immunoprecipitated with an Oct4 antibody (Santa Cruz)
coupled to Dynal-Protein G beads (Invitrogen). Immunoprecipitates were
eluted by boiling in 13 LDS loading buffer (Invitrogen) and separated by
LDS-PAGE (Invitrogen). Western blotting was carried out with antibodies
from Abcam (Parp1, Sall4, and Myst2), Bethyl Laboratories (Chd4), or Santa
Cruz (Oct4 and Hdac1).
Mass Spectrometry and Data Analysis
Peptides were redissolved in 0.5% formic acid and analyzed with online
nanoLC-MS/MS on a LTQ FT mass spectrometer (Thermo Fisher Scientific)
coupled with an Ultimate 3000 Nano/Capillary LC System (Dionex). Samples
were first loaded and desalted on a trap (0.3 mm id 3 5 mm) at 25 mL/min
with 0.1% formic acid for 5 min and then separated on an analytical column
(75 mm id 3 15 cm) (both PepMap C18, LC Packings) over a 30 min linear
gradient of 4%–32% CH3CN/0.1% formic acid at 300 nL/min. The LTQ FT
was operated in standard data-dependent acquisition. The survey scans
(m/z 400–2000) were acquired on the FT-ICR at a resolution of 100,000 at
m/z 400, and one microscan was acquired per spectrum. The three most
abundant multiply charged ions with a minimal intensity of 1000 counts were
subject to MS/MS in the linear ion trap at an isolation width of 3 Th. Dynamic392 Cell Stem Cell 6, 382–395, April 2, 2010 ª2010 Elsevier Inc.exclusion width was set at ± 10 ppm for 45 s. The automatic gain control target
value was regulated at 5E5 for FT and 1E4 for the ion trap, with maximum injec-
tion time at 1000 ms for FT and 200 ms for the ion trap, respectively.
The raw files were processed with BioWorks (Thermo). Database searches
were performed with Mascot v.2.1 (Matrix Science) against the mouse
IPI database (v. January 2009). The search parameters were: Trypsin/P with
two missed cleavages, 10 ppm mass tolerance for MS, 0.5 Da tolerance for
MS/MS, fixed modification Carbamidomethyl (C), and variable modifications
of Acetyl (Protein N-term), Deamidated (NQ), Dioxidation (M), Formyl
(N-term), Gln- > pyro-Glu (N-term Q), Methyl (E), and Oxidation (M). Decoy
database searches were performed at the same time as the real searches,
resulting in false discovery rates under 5%.
Only peptides with scores above 20 were used in the analysis. Protein iden-
tification required at least one high-confidence peptide (peptide score above
identity threshold, e % 0.05, length > 8 aas, precursor ion mass accuracy <
5 ppm where e R 0.005, peptide hit rank 1, and delta peptide score > 10).
There is increased risk of false discovery when a protein is identified by only
one peptide. Thus, all peptides identifying a protein without additional support
met the strict confidence requirements above and were manually verified.
Precursor ion mass accuracies of these peptides are shown in Table S1.
Mascot results were clustered to 95% protein homology to collapse highly
homologous sequences corresponding to the same gene, and all lists for
target and control purifications were compared in parallel. External contami-
nants (keratins, albumin, casein, and TEV protease) were excluded from the
list. In the final list of Oct4-associated proteins we report only proteins identi-
fied in all three replicates. We have chosen one representative of each protein
cluster, the one with the highest number of peptide matches, meaningful gene
symbol, and highest molecular weight.
Computational and Systems-Level Analysis
Orthologous human proteins were identified with the g:Profiler orthology
search tool (Reimand et al., 2007) or NCBI BLASTP and aligned with the Nee-
dleman-Wunsch algorithm. For assessment of the degree of conservation
between the Oct4-associated proteins and their orthologs, sequence identi-
ties of all mouse-to-human ortholog pairs of comparable sequence length in
ENSEMBL release 57 were compared via a Mann-Whitney U test.
Domains were identified with Pfam 24.0, and genome-wide frequencies
were calculated from domain annotations in UniProtKB/Swiss-Prot release
15.15 (Uniprot Consortium, 2010).
Mammalian Phenotype Ontology annotations were obtained from the
Mouse Genome Informatics project (Blake et al., 2009), human disease asso-
ciations were obtained from OMIM (Hamosh et al., 2005), and known cancer-
causing mutations in genes were obtained from the Cancer Gene Census
(Futreal et al., 2004). Student’s t test was used for assessing the significance
of the observed numbers of Oct4-associated genes with lethal phenotypes,
disease, and cancer associations against 1000 random sets of 92 genes, in
each case.
ChIP-on-chip data were obtained for Oct4 and eight other transcription
factors (Kim et al., 2008). The significance of the number of Oct4-associated
proteins regulated by these factors was assessed against 1000 random sets
of 92 genes. The protein interaction network was generated with Cytoscape
2.6.3 (Cline et al., 2007), with a spring-embedded layout.
For the analysis of expression at different stages of differentiation, data were
obtained for 43 mouse samples in StemBase (Sandie et al., 2009), originating
from 16 studies with AffymetrixMOE430Amicroarray chips, as used in anOct4
expression profiling study (Campbell et al., 2007) covering murine ESCs,
embryonal carcinoma cell lines, and several early differentiated lineages.
Expression data was available for 70 of the 92 Oct4-associated proteins.
Where multiple probes were available, expression was averaged. Student’s
t test was used for identifying genes differentially expressed in ESCs as
compared to more differentiated cell types (Bonferroni-corrected for multiple
testing). Expression values were log2-transformed and color-coded as a
gradient from blue (more than twice the standard deviation below the global
microarray mean) via black (microarray mean) to yellow (more than twice the
standard deviation above the mean). Average-linkage hierarchical clustering
was performed to arrive at the final layout.
Data on significantly misexpressed genes was curated from the Oncomine
human cancer expression database (Rhodes et al., 2007). Genes were
Cell Stem Cell
An Expanded Oct4 Interaction Networkconsidered mis-expressed below a p-value threshold of 1010 (Bonferroni-
corrected for multiple testing).
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